Viral Clearance Using Traditional, Well-Understood Unit Operations (Session I): Low-pH Inactivation

Qi Chen

doi:10.5731/pdajpst.2014.00962

Research ArticleConference Proceeding - Article

Viral Clearance Using Traditional, Well-Understood Unit Operations (Session I): Low-pH Inactivation

Qi Chen

PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 17-22; DOI: https://doi.org/10.5731/pdajpst.2014.00962

Qi Chen

Genentech, a Member of the Roche Group; Process Virology, 1 DNA Way, Mailstop 10, South San Francisco, CA 94080

Ph.D.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
References
Info & Metrics
PDF

Article Information

vol. 68 no. 1 17-22

DOI

https://doi.org/10.5731/pdajpst.2014.00962

PubMed

24504232

Published By

Parenteral Drug Association (PDA)

Print ISSN

1079-7440

Online ISSN

1948-2124

History

Published online February 6, 2014.

Author Information

Cited By...

10 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Stress Factors in mAb Drug Substance Production Processes: Critical Assessment of Impact on Product Quality and Control Strategy

Tapan K. Das, Linda O. Narhi, Alavattam Sreedhara, Tim Menzen, Christoph Grapentin, Danny K. Chou, Valentyn Antochshuk, Vasco Filipe

Journal of Pharmaceutical Sciences 2020 109 1
Viral clearance for biopharmaceutical downstream processes

Abhinav A Shukla, Hazel Aranha

Pharmaceutical Bioprocessing 2015 3 2
Continuous In‐Line Virus Inactivation for Next Generation Bioprocessing

Christopher Gillespie, Melissa Holstein, Lori Mullin, Kristen Cotoni, Ronald Tuccelli, John Caulmare, Patricia Greenhalgh

Biotechnology Journal 2019 14 2
Characterization of operating parameters for XMuLV inactivation by low pH treatment

Shivanthi Chinniah, Peter Hinckley, Lisa Connell-Crowley

Biotechnology Progress 2016 32 1
Application of Formulation Principles to Stability Issues Encountered During Processing, Manufacturing, and Storage of Drug Substance and Drug Product Protein Therapeutics

Samadhi Vitharana, Joshua M. Stillahn, Derrick S. Katayama, Charles S. Henry, Mark Cornell Manning

Journal of Pharmaceutical Sciences 2023 112 11
Suitability of a generic virus safety evaluation for monoclonal antibody investigational new drug applications

Patrick Sipple, Tung Nguyen, Krina Patel, Neil Jaffe, Yan Chen, Anurag Khetan

Biotechnology Progress 2019 35 5
Optimization of non-detergent treatment for enveloped virus inactivation using the Taguchi design of experimental methodology (DOE)

Roya Khosravi, Seyed Nezamedin Hosseini, Amin Javidanbardan, Maryam Khatami, Hooman Kaghazian, Seyed Dawood Mousavi Nasab

Preparative Biochemistry and Biotechnology 2019 49 7
Risk management for viral clearance: A case study on adoption of platform validation approach and risk management of process changes

Na Liu, Runze Wu

Biologicals 2024 87
Therapeutic Monoclonal Antibodies - From Lot Release to Stability Testing

Harleen Kaur

2024
Viral clearance capability of monoclonal antibody purification

Kang Cai, Jennifer Anderson, Etienne Utiger, Gisela Ferreira

Biologicals 2024 85

PreviousNext

In This Issue

PDA Journal of Pharmaceutical Science and Technology

Vol. 68, Issue 1

January/February 2014

Table of Contents
Index by Author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Viral Clearance Using Traditional, Well-Understood Unit Operations (Session I): Low-pH Inactivation

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 3 + 15 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Viral Clearance Using Traditional, Well-Understood Unit Operations (Session I): Low-pH Inactivation

Qi Chen

PDA Journal of Pharmaceutical Science and Technology Jan 2014, 68 (1) 17-22; DOI: 10.5731/pdajpst.2014.00962

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Viral Clearance Using Traditional, Well-Understood Unit Operations (Session I): Low-pH Inactivation

Qi Chen

PDA Journal of Pharmaceutical Science and Technology Jan 2014, 68 (1) 17-22; DOI: 10.5731/pdajpst.2014.00962

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
References
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Using Sensitivity Analysis to Simplify the Virus Safety Factor Calculation in the Manufacture of Biopharmaceuticals

Google Scholar

Main menu

User menu

Search

Viral Clearance Using Traditional, Well-Understood Unit Operations (Session I): Low-pH Inactivation

Article Information

Author Information

Cited By...

In This Issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.